Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IM Cannabis Corp. (IMCC : NSDQ)
 
 • Company Description   
IM Cannabis Corp. is an MCO in the medical and adult-use recreational cannabis sector. It operates principally in Israel, Germany and Canada. IM Cannabis Corp. is headquartered in Israel.

Number of Employees: 44

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.24 Daily Weekly Monthly
20 Day Moving Average: 823,621 shares
Shares Outstanding: 6.22 (millions)
Market Capitalization: $1.51 (millions)
Beta: 2.00
52 Week High: $7.12
52 Week Low: $0.22
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -36.60% -40.49%
12 Week -74.42% -76.60%
Year To Date -82.52% -84.05%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3606 - 833 SEYMOUR STREET
-
VANCOUVER,A1 V6B 0G4
CAN
ph: 972-54-433-1111
fax: -
maya.l@imcannabis.com http://www.imcannabis.com
 
 • General Corporate Information   
Officers
Oren Shuster - Chief Executive Officer and Director
Oz Adler - Chairman
Asi Levi - Chief Financial Officer
Alon Dayan - Director
Assaf Yitzhaik - Director

Peer Information
IM Cannabis Corp. (BJCT)
IM Cannabis Corp. (CADMQ)
IM Cannabis Corp. (APNO)
IM Cannabis Corp. (UPDC)
IM Cannabis Corp. (IMTIQ)
IM Cannabis Corp. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 44969Q406
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/11/26
Share - Related Items
Shares Outstanding: 6.22
Most Recent Split Date: 7.00 (0.17:1)
Beta: 2.00
Market Capitalization: $1.51 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 0.04
EPS Growth
vs. Year Ago Period: -566.67%
vs. Previous Quarter: 67.44%
Sales Growth
vs. Year Ago Period: -27.33%
vs. Previous Quarter: -43.76%
ROE
03/31/26 - -879.10
12/31/25 - -585.96
09/30/25 - -134.35
ROA
03/31/26 - -39.96
12/31/25 - -28.74
09/30/25 - -11.66
Current Ratio
03/31/26 - 0.55
12/31/25 - 0.67
09/30/25 - 0.82
Quick Ratio
03/31/26 - -
12/31/25 - 0.54
09/30/25 - 0.56
Operating Margin
03/31/26 - -27.65
12/31/25 - -21.24
09/30/25 - -9.47
Net Margin
03/31/26 - -27.65
12/31/25 - -21.24
09/30/25 - -9.47
Pre-Tax Margin
03/31/26 - -27.91
12/31/25 - -21.30
09/30/25 - -9.61
Book Value
03/31/26 - -0.60
12/31/25 - -0.49
09/30/25 - 0.60
Inventory Turnover
03/31/26 - 8.65
12/31/25 - 7.69
09/30/25 - 7.15
Debt-to-Equity
03/31/26 - -
12/31/25 - -
09/30/25 - 0.25
Debt-to-Capital
03/31/26 - -
12/31/25 - -
09/30/25 - 20.04
 

Powered by Zacks Investment Research ©